Paper19620144
Systematic review: glucose control and cardiovascular disease in type 2 diabetes.
Kelly TN and 5 others. Ann Intern Med, 2009. Cited by 258 papers, by iCite.
Cite this record
ConductScience Library. Systematic review: glucose control and cardiovascular disease in type 2 diabetes. Papers, record 19620144. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19620144
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Meta-Analysis, Research Support, N.I.H., Extramural, Systematic Review
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cardiovascular Diseases | Major topic |
| Diabetes Mellitus, Type 2 | Major topic |
| Hypoglycemic Agents | Major topic |
| Blood Glucose | |
| Cause of Death | |
| Humans | |
| Hypoglycemia | |
| Risk Factors |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| K08 HL091108 | NHLBI NIH HHS | United States | K08HL091108 | PubMed and NIH | NIH RePORTER |
| K12 HD043451 | NICHD NIH HHS | United States | K12HD043451 | PubMed and NIH | NIH RePORTER |
| 1K08HL091108 | NHLBI NIH HHS | United States | K08HL091108 | PubMed and NIH | NIH RePORTER |
| K12HD043451 | NICHD NIH HHS | United States | K12HD043451 | PubMed and NIH | NIH RePORTER |
Comments and corrections4
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 20048277 | Concerns about meta-analysis of glucose control and cardiovascular disease in type 2 diabetes. | https://conductscience.org/library/papers/20048277 | PubMed |
| Comment in | 20052788 | Correction: glucose control and cardiovascular disease in type 2 diabetes. | https://conductscience.org/library/papers/20052788 | PubMed |
| Comment in | 20166054 | [Strict blood glucose control not absolutely required in type 2 diabetes mellitus?]. | https://conductscience.org/library/papers/20166054 | PubMed |
| Comment in | 20179047 | Intensive glucose control in type 2 diabetes reduces cardiovascular disease, but not cardiovascular or all-cause mortality, and increases risk of severe hypoglycaemia. | https://conductscience.org/library/papers/20179047 | PubMed |
References33
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19502645 | A randomized trial of therapies for type 2 diabetes and coronary artery disease. | N Engl J Med | 2009 | https://conductscience.org/library/papers/19502645 | PubMed |
| 2 | 430798 | Diabetes and cardiovascular disease. The Framingham study. | JAMA | 1979 | https://conductscience.org/library/papers/430798 | PubMed |
| 3 | 12556541 | Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. | N Engl J Med | 2003 | https://conductscience.org/library/papers/12556541 | PubMed |
| 4 | 17517853 | Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. | N Engl J Med | 2007 | https://conductscience.org/library/papers/17517853 | PubMed |
| 5 | 15562129 | Trends in cardiovascular complications of diabetes. | JAMA | 2004 | https://conductscience.org/library/papers/15562129 | PubMed |
| 6 | 17765963 | Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. | Lancet | 2007 | https://conductscience.org/library/papers/17765963 | PubMed |
| 7 | 19465231 | Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. | Lancet | 2009 | https://conductscience.org/library/papers/19465231 | PubMed |
| 8 | 19092145 | Glucose control and vascular complications in veterans with type 2 diabetes. | N Engl J Med | 2009 | https://conductscience.org/library/papers/19092145 | PubMed |
| 9 | 9009975 | Cardiovascular events and correlates in the Veterans Affairs Diabetes Feasibility Trial. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes. | Arch Intern Med | 1997 | https://conductscience.org/library/papers/9009975 | PubMed |
| 10 | 10938048 | Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. | BMJ | 2000 | https://conductscience.org/library/papers/10938048 | PubMed |
| 11 | 3802833 | Meta-analysis in clinical trials. | Control Clin Trials | 1986 | https://conductscience.org/library/papers/3802833 | PubMed |
| 12 | 15381515 | Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. | Ann Intern Med | 2004 | https://conductscience.org/library/papers/15381515 | PubMed |
| 13 | 11742409 | Global and societal implications of the diabetes epidemic. | Nature | 2001 | https://conductscience.org/library/papers/11742409 | PubMed |
| 14 | 10860187 | Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients. | Diabetes Care | 2000 | https://conductscience.org/library/papers/10860187 | PubMed |
| 15 | 11559264 | The continuing epidemics of obesity and diabetes in the United States. | JAMA | 2001 | https://conductscience.org/library/papers/11559264 | PubMed |
| 16 | 18539918 | Intensive glycemic control in the ACCORD and ADVANCE trials. | N Engl J Med | 2008 | https://conductscience.org/library/papers/18539918 | PubMed |
| 17 | 9742976 | Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. | Lancet | 1998 | https://conductscience.org/library/papers/9742976 | PubMed |
| 18 | 19380837 | Glycemic control in type 2 diabetes: time for an evidence-based about-face? | Ann Intern Med | 2009 | https://conductscience.org/library/papers/19380837 | PubMed |
| 19 | 17098083 | Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment. | Lancet | 2006 | https://conductscience.org/library/papers/17098083 | PubMed |
| 20 | 16824829 | Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials. | Am Heart J | 2006 | https://conductscience.org/library/papers/16824829 | PubMed |
Cited by133
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 258 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41582990 | A Decade On: The Evolving Renaissance in Intracranial Atherosclerotic Disease. | Stroke Vasc Interv Neurol | 2022 | https://conductscience.org/library/papers/41582990 | PubMed |
| 41567802 | Changes of the cardiac electrical cycle in type 1 diabetes during hypoglycaemia - a prospective observational study. | Front Endocrinol (Lausanne) | 2025 | https://conductscience.org/library/papers/41567802 | PubMed |
| 41559660 | Cost of diabetes and hypertension services delivered in primary and secondary-level government facilities in Punjab, India. | BMC Health Serv Res | 2026 | https://conductscience.org/library/papers/41559660 | PubMed |
| 41034186 | History of Hypertension From Childhood and Fasting Blood Glucose Levels in Adulthood: The Bogalusa Study. | J Diabetes | 2025 | https://conductscience.org/library/papers/41034186 | PubMed |
| 40477401 | Crocodile blood supplementation protects vascular function in diabetic mice. | Food Prod Process Nutr | 2021 | https://conductscience.org/library/papers/40477401 | PubMed |
| 40329991 | Morbidity-bridging metabolic pathways: linking early cardiovascular disease risk and depression symptoms using a multi-modal approach. | Eur Heart J Open | 2025 | https://conductscience.org/library/papers/40329991 | PubMed |
| 39339760 | Licorice Extract Isoliquiritigenin Protects Endothelial Function in Type 2 Diabetic Mice. | Nutrients | 2024 | https://conductscience.org/library/papers/39339760 | PubMed |
| 39156155 | Cardioprotective Effect of SGLT2 Inhibitor in Diabetic Kidney Transplant Recipients: A Multicenter Propensity Score Matched Study. | Kidney Int Rep | 2024 | https://conductscience.org/library/papers/39156155 | PubMed |
| 37746464 | Exploring the Relation Between Diabetes and HIV: A Narrative Review. | Cureus | 2023 | https://conductscience.org/library/papers/37746464 | PubMed |
| 37645418 | Association of hypoglycaemia with the risks of arrhythmia and mortality in individuals with diabetes - a systematic review and meta-analysis. | Front Endocrinol (Lausanne) | 2023 | https://conductscience.org/library/papers/37645418 | PubMed |
| 36941489 | Weight Loss Versus Glycemic Control as the Primary Treatment Target in Newly Diagnosed Type 2 Diabetes: Why Choose When You Can Have Both? | Drugs | 2023 | https://conductscience.org/library/papers/36941489 | PubMed |
| 36574434 | Effect of repeated bolus and continuous glucose infusion on a panel of circulating biomarkers in healthy volunteers. | PLoS One | 2022 | https://conductscience.org/library/papers/36574434 | PubMed |
| 36432488 | Remission as an Emerging Therapeutic Target in Type 2 Diabetes in the Era of New Glucose-Lowering Agents: Benefits, Challenges, and Treatment Approaches. | Nutrients | 2022 | https://conductscience.org/library/papers/36432488 | PubMed |
| 36299875 | Hypoglycemia is associated with a higher risk of mortality and arrhythmias in ST-elevation myocardial infarction, irrespective of diabetes. | Front Cardiovasc Med | 2022 | https://conductscience.org/library/papers/36299875 | PubMed |
| 35929480 | Reconsidering the role of glycaemic control in cardiovascular disease risk in type 2 diabetes: A 21st century assessment. | Diabetes Obes Metab | 2022 | https://conductscience.org/library/papers/35929480 | PubMed |
| 34902079 | Value of Patient-Centered Glycemic Control in Patients with Type 2 Diabetes. | Curr Diab Rep | 2021 | https://conductscience.org/library/papers/34902079 | PubMed |
| 34795807 | mtDNA in the Pathogenesis of Cardiovascular Diseases. | Dis Markers | 2021 | https://conductscience.org/library/papers/34795807 | PubMed |
| 34277996 | Association of type 2 diabetes remission and risk of cardiovascular disease in pre-defined subgroups. | Endocrinol Diabetes Metab | 2021 | https://conductscience.org/library/papers/34277996 | PubMed |
| 34258663 | Risk factor management and OCT characteristics of plaque vulnerability: the Holy Grail of plaque and patient vulnerability. | Int J Cardiovasc Imaging | 2022 | https://conductscience.org/library/papers/34258663 | PubMed |
| 34177225 | Enhancing Diabetes Self-Management Education and Psychological Services for Veterans With Comorbid Chronic Health and Mental Health Conditions. | Fed Pract | 2021 | https://conductscience.org/library/papers/34177225 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19620144
GET https://conductscience.org/api/papers/v1/19620144/references?page=2